Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival

Published:2020-10-30 Issue:8 Volume:122 Page:1761-1769
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Sutton Thomas L.¹^ORCID,Schlitt Alexander²,Gardiner Stuart K.³,Johnson Nathalie⁴,Garreau Jennifer R.⁴

Affiliation:

1. Department of Surgery Oregon Health & Science University Portland Oregon USA

2. College of Osteopathic Medicine of the Pacific‐Northwest Western University Of Health Sciences Lebanon Oregon USA

3. Devers Eye Institute, Legacy Research Institute Legacy Health Portland Oregon USA

4. Legacy Cancer Institute Legacy Medical Group Surgical Oncology Portland Oregon USA

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.26216

Reference14 articles.

1. Appropriate timing of surgery after neoadjuvant chemoradiation therapy for locally advanced rectal cancer;Garrer WY;Asian Pac J Cancer Prev,2016

2. Randomized clinical trial of short or long interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer;Akgun E;Br J Surg,2018

3. Impact of interval between neoadjuvant chemoradiation and surgery upon morbidity and survival of patients with squamous cell carcinoma of thoracic esophagus;Furukawa T;Anticancer Res,2018

4. Impact of the Time Interval from Neoadjuvant Chemotherapy to Surgery in Primary Ovarian, Tubal, and Peritoneal Cancer Patients

5. Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time to surgery after completion of neoadjuvant chemotherapy does not negatively impact recurrence and survival outcomes in breast cancer patients;World Journal of Surgery;2024-06-17

2. Ethnoracial Disparities in Breast Cancer Treatment Time and Survival: A Systematic Review With a DAG-based Causal Model;2024-06-03

3. Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer;Annals of Surgical Oncology;2024-05-20

4. Predictive Factors of Neoadjuvant Chemotherapy Response in Breast Cancer Validated by Three Anatomopathological Scores: Residual Cancer Burden, Chevallier System, and Tumor-Infiltrating Lymphocytes;Cureus;2024-04-30

5. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer;Breast Cancer Research and Treatment;2024-01-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3